Publications

Authors:

Danese, Elisabetta; Curic, Tea; Bellinato, Francesco; Colato, Chiara; Gisondi, Paolo; Girolomoni, Giampiero

Title:

Upadacitinib in refractory cutaneous pseudolymphoma: A case report

Year:

2025

Type of item:

Articolo in Rivista

Tipologia ANVUR:

Articolo su rivista

Language:

Inglese

Referee:

No

Name of journal:

SAGE OPEN MEDICAL CASE REPORTS

ISSN of journal:

2050-313X

Page numbers:

1-4

Keyword:

upadacitinib, cutaneous pseudolymphoma, JAK inhibitors

Short description of contents:

Cutaneous pseudolymphoma is a benign condition characterized by a reactive B-cell, T-cell or mixed lymphoproliferative process. Different causative agents (e.g. injected substances, tattoo, drugs and insect bites) have been described, but in many cases no cause can be identified; hence, the term idiopathic cutaneous pseudolymphoma. There are no specific guidelines for the treatment of cutaneous pseudolymphoma, and sometimes a few cases are refractory to conventional treatments. We describe a case of a 41-year-old African woman with refractory facial IgG4 pseudolymphoma successfully treated with upadacitinib.

Product ID:

146520

Handle IRIS:

11562/1165707

Last Modified:

June 27, 2025

Bibliographic citation:

Danese, Elisabetta; Curic, Tea; Bellinato, Francesco; Colato, Chiara; Gisondi, Paolo; Girolomoni, Giampiero, Upadacitinib in refractory cutaneous pseudolymphoma: A case report «SAGE OPEN MEDICAL CASE REPORTS» , 2025 , pp. 1-4

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo